AcelRx Pharmaceuticals announces publication analyzing pooled data on sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain

Stock Information for AcelRx Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.